{"id":870246,"date":"2025-08-04T14:19:40","date_gmt":"2025-08-04T18:19:40","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-hillevax-inc-nasdaq-hlvx-steelcase-inc-nyse-scs-lava-therapeutics-n-v-nasdaq\/"},"modified":"2025-08-04T14:19:40","modified_gmt":"2025-08-04T18:19:40","slug":"brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-hillevax-inc-nasdaq-hlvx-steelcase-inc-nyse-scs-lava-therapeutics-n-v-nasdaq","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-hillevax-inc-nasdaq-hlvx-steelcase-inc-nyse-scs-lava-therapeutics-n-v-nasdaq\/","title":{"rendered":"BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: HilleVax, Inc. (Nasdaq \u2013 HLVX), Steelcase Inc. (NYSE \u2013 SCS), LAVA Therapeutics N.V. (Nasdaq\u00a0\u2013 LVTX), Arcadia Biosciences, Inc. (Nasdaq\u00a0\u2013 RKDA)"},"content":{"rendered":"
\n

BALA CYNWYD, Pa., Aug. 04, 2025 (GLOBE NEWSWIRE) — Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com<\/a>) or Marc Ackerman (mackerman@brodskysmith.com<\/a>) at 855-576-4847. There is no cost or financial obligation to you.<\/p>\n

\n HilleVax, Inc. (Nasdaq \u2013 HLVX)<\/strong>\n <\/p>\n

Under the terms of the Merger Agreement, HilleVax will be acquired by XOMA Royalty Corporation (\u201cXOMA Royalty\u201d) (Nasdaq – XOMA) for $1.95 in cash per share plus one non-transferable contingent value right (\u201cCVR\u201d). The investigation concerns whether the HilleVax Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the consideration provides fair value to the Company\u2019s shareholders.<\/p>\n

Additional information can be found at https:\/\/www.brodskysmith.com\/cases\/hillevax-inc-nasdaq-hlvx\/<\/a>.<\/p>\n

\n Steelcase Inc. (NYSE \u2013 SCS)<\/strong>\n <\/p>\n

Under the terms of the agreement, Steelcase will be acquired by HNI Corporation (NYSE: HNI) for $7.20 in cash and 0.2192 shares of HNI common stock for each share of Steelcase they own. The implied per share purchase price is $18.30 based on HNI\u2019s closing share price of $50.62 on August 1, 2025. The investigation concerns whether the Steelcase Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the consideration provides fair value to the Company\u2019s shareholders.<\/p>\n

Additional information can be found at https:\/\/www.brodskysmith.com\/cases\/steelcase-inc-nyse-scs\/<\/a>.<\/p>\n

\n LAVA Therapeutics N.V. (Nasdaq\u00a0\u2013 LVTX)<\/strong>\n <\/p>\n

Under the terms of the Merger Agreement, LAVA will be acquired by XOMA Royalty Corporation (\u201cXOMA Royalty\u201d) (Nasdaq – XOMA) for (i) between $1.16 and $1.24 per share in cash, consisting of (A) USD $1.16 (the \u201cBase Price Per Share\u201d) in cash per share (the \u201cLAVA common stock\u201d), plus (B) an additional amount of cash of up to $0.08 per Share (such amount as finally determined in accordance with the Purchase Agreement, the \u201cAdditional Price Per Share,\u201d and together with the Base Price Per Share, the \u201cCash Amount\u201d), plus (ii) a non-transferable contingent value right (\u201cCVR\u201d) per share representing the right to receive 75% of the net proceeds related to LAVA\u2019s two partnered assets and 75% of any net proceeds from any out license or sale of LAVA\u2019s unpartnered programs. The investigation concerns whether the LAVA Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the consideration provides fair value to the Company\u2019s shareholders.<\/p>\n

Additional information can be found at https:\/\/www.brodskysmith.com\/cases\/lava-therapeutics-n-v-nasdaq-lvtx\/<\/a>.<\/p>\n

\n Arcadia Biosciences, Inc. (Nasdaq\u00a0\u2013 RKDA)<\/strong>\n <\/p>\n

Under the terms of the agreement, Arcadia will be acquired by Roosevelt Resources LP. Following the closing of the transaction, the current equity owners of Roosevelt and the Arcadia shareholders as of the closing are expected to own approximately 90% and 10%, respectively. The investigation concerns whether the Arcadia Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including the dilution of the Company\u2019s shareholders in the combined company.<\/p>\n

Additional information can be found at https:\/\/www.brodskysmith.com\/cases\/arcadia-biosciences-inc-nasdaq-rkda\/<\/a> .<\/p>\n

Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.<\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

BALA CYNWYD, Pa., Aug. 04, 2025 (GLOBE NEWSWIRE) — Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you. HilleVax, Inc. (Nasdaq \u2013 HLVX) Under the terms of the Merger Agreement, HilleVax will be acquired by XOMA Royalty Corporation (\u201cXOMA Royalty\u201d) (Nasdaq – XOMA) for $1.95 in cash per share plus one non-transferable contingent value right (\u201cCVR\u201d). The investigation concerns whether the HilleVax Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the consideration provides fair value to the Company\u2019s shareholders. Additional information can be … <\/p>\n

Continue reading “BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: HilleVax, Inc. (Nasdaq \u2013 HLVX), Steelcase Inc. (NYSE \u2013 SCS), LAVA Therapeutics N.V. (Nasdaq\u00a0\u2013 LVTX), Arcadia Biosciences, Inc. (Nasdaq\u00a0\u2013 RKDA)”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-870246","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nBRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: HilleVax, Inc. (Nasdaq \u2013 HLVX), Steelcase Inc. (NYSE \u2013 SCS), LAVA Therapeutics N.V. (Nasdaq\u00a0\u2013 LVTX), Arcadia Biosciences, Inc. (Nasdaq\u00a0\u2013 RKDA) - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-hillevax-inc-nasdaq-hlvx-steelcase-inc-nyse-scs-lava-therapeutics-n-v-nasdaq\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: HilleVax, Inc. (Nasdaq \u2013 HLVX), Steelcase Inc. (NYSE \u2013 SCS), LAVA Therapeutics N.V. (Nasdaq\u00a0\u2013 LVTX), Arcadia Biosciences, Inc. (Nasdaq\u00a0\u2013 RKDA) - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BALA CYNWYD, Pa., Aug. 04, 2025 (GLOBE NEWSWIRE) — Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you. HilleVax, Inc. (Nasdaq \u2013 HLVX) Under the terms of the Merger Agreement, HilleVax will be acquired by XOMA Royalty Corporation (\u201cXOMA Royalty\u201d) (Nasdaq – XOMA) for $1.95 in cash per share plus one non-transferable contingent value right (\u201cCVR\u201d). The investigation concerns whether the HilleVax Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the consideration provides fair value to the Company\u2019s shareholders. Additional information can be … Continue reading "BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: HilleVax, Inc. (Nasdaq \u2013 HLVX), Steelcase Inc. (NYSE \u2013 SCS), LAVA Therapeutics N.V. (Nasdaq\u00a0\u2013 LVTX), Arcadia Biosciences, Inc. (Nasdaq\u00a0\u2013 RKDA)"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-hillevax-inc-nasdaq-hlvx-steelcase-inc-nyse-scs-lava-therapeutics-n-v-nasdaq\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-04T18:19:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUwNTU3NiM3MDgwMTMzIzIxODgyNzg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-hillevax-inc-nasdaq-hlvx-steelcase-inc-nyse-scs-lava-therapeutics-n-v-nasdaq\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-hillevax-inc-nasdaq-hlvx-steelcase-inc-nyse-scs-lava-therapeutics-n-v-nasdaq\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: HilleVax, Inc. (Nasdaq \u2013 HLVX), Steelcase Inc. (NYSE \u2013 SCS), LAVA Therapeutics N.V. (Nasdaq\u00a0\u2013 LVTX), Arcadia Biosciences, Inc. (Nasdaq\u00a0\u2013 RKDA)\",\"datePublished\":\"2025-08-04T18:19:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-hillevax-inc-nasdaq-hlvx-steelcase-inc-nyse-scs-lava-therapeutics-n-v-nasdaq\\\/\"},\"wordCount\":589,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-hillevax-inc-nasdaq-hlvx-steelcase-inc-nyse-scs-lava-therapeutics-n-v-nasdaq\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUwNTU3NiM3MDgwMTMzIzIxODgyNzg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-hillevax-inc-nasdaq-hlvx-steelcase-inc-nyse-scs-lava-therapeutics-n-v-nasdaq\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-hillevax-inc-nasdaq-hlvx-steelcase-inc-nyse-scs-lava-therapeutics-n-v-nasdaq\\\/\",\"name\":\"BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: HilleVax, Inc. (Nasdaq \u2013 HLVX), Steelcase Inc. (NYSE \u2013 SCS), LAVA Therapeutics N.V. (Nasdaq\u00a0\u2013 LVTX), Arcadia Biosciences, Inc. (Nasdaq\u00a0\u2013 RKDA) - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-hillevax-inc-nasdaq-hlvx-steelcase-inc-nyse-scs-lava-therapeutics-n-v-nasdaq\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-hillevax-inc-nasdaq-hlvx-steelcase-inc-nyse-scs-lava-therapeutics-n-v-nasdaq\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUwNTU3NiM3MDgwMTMzIzIxODgyNzg=\",\"datePublished\":\"2025-08-04T18:19:40+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-hillevax-inc-nasdaq-hlvx-steelcase-inc-nyse-scs-lava-therapeutics-n-v-nasdaq\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-hillevax-inc-nasdaq-hlvx-steelcase-inc-nyse-scs-lava-therapeutics-n-v-nasdaq\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-hillevax-inc-nasdaq-hlvx-steelcase-inc-nyse-scs-lava-therapeutics-n-v-nasdaq\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUwNTU3NiM3MDgwMTMzIzIxODgyNzg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUwNTU3NiM3MDgwMTMzIzIxODgyNzg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-hillevax-inc-nasdaq-hlvx-steelcase-inc-nyse-scs-lava-therapeutics-n-v-nasdaq\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: HilleVax, Inc. (Nasdaq \u2013 HLVX), Steelcase Inc. (NYSE \u2013 SCS), LAVA Therapeutics N.V. (Nasdaq\u00a0\u2013 LVTX), Arcadia Biosciences, Inc. (Nasdaq\u00a0\u2013 RKDA)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: HilleVax, Inc. (Nasdaq \u2013 HLVX), Steelcase Inc. (NYSE \u2013 SCS), LAVA Therapeutics N.V. (Nasdaq\u00a0\u2013 LVTX), Arcadia Biosciences, Inc. (Nasdaq\u00a0\u2013 RKDA) - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-hillevax-inc-nasdaq-hlvx-steelcase-inc-nyse-scs-lava-therapeutics-n-v-nasdaq\/","og_locale":"en_US","og_type":"article","og_title":"BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: HilleVax, Inc. (Nasdaq \u2013 HLVX), Steelcase Inc. (NYSE \u2013 SCS), LAVA Therapeutics N.V. (Nasdaq\u00a0\u2013 LVTX), Arcadia Biosciences, Inc. (Nasdaq\u00a0\u2013 RKDA) - Market Newsdesk","og_description":"BALA CYNWYD, Pa., Aug. 04, 2025 (GLOBE NEWSWIRE) — Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you. HilleVax, Inc. (Nasdaq \u2013 HLVX) Under the terms of the Merger Agreement, HilleVax will be acquired by XOMA Royalty Corporation (\u201cXOMA Royalty\u201d) (Nasdaq – XOMA) for $1.95 in cash per share plus one non-transferable contingent value right (\u201cCVR\u201d). The investigation concerns whether the HilleVax Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the consideration provides fair value to the Company\u2019s shareholders. Additional information can be … Continue reading \"BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: HilleVax, Inc. (Nasdaq \u2013 HLVX), Steelcase Inc. (NYSE \u2013 SCS), LAVA Therapeutics N.V. (Nasdaq\u00a0\u2013 LVTX), Arcadia Biosciences, Inc. (Nasdaq\u00a0\u2013 RKDA)\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-hillevax-inc-nasdaq-hlvx-steelcase-inc-nyse-scs-lava-therapeutics-n-v-nasdaq\/","og_site_name":"Market Newsdesk","article_published_time":"2025-08-04T18:19:40+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUwNTU3NiM3MDgwMTMzIzIxODgyNzg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-hillevax-inc-nasdaq-hlvx-steelcase-inc-nyse-scs-lava-therapeutics-n-v-nasdaq\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-hillevax-inc-nasdaq-hlvx-steelcase-inc-nyse-scs-lava-therapeutics-n-v-nasdaq\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: HilleVax, Inc. (Nasdaq \u2013 HLVX), Steelcase Inc. (NYSE \u2013 SCS), LAVA Therapeutics N.V. (Nasdaq\u00a0\u2013 LVTX), Arcadia Biosciences, Inc. (Nasdaq\u00a0\u2013 RKDA)","datePublished":"2025-08-04T18:19:40+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-hillevax-inc-nasdaq-hlvx-steelcase-inc-nyse-scs-lava-therapeutics-n-v-nasdaq\/"},"wordCount":589,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-hillevax-inc-nasdaq-hlvx-steelcase-inc-nyse-scs-lava-therapeutics-n-v-nasdaq\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUwNTU3NiM3MDgwMTMzIzIxODgyNzg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-hillevax-inc-nasdaq-hlvx-steelcase-inc-nyse-scs-lava-therapeutics-n-v-nasdaq\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-hillevax-inc-nasdaq-hlvx-steelcase-inc-nyse-scs-lava-therapeutics-n-v-nasdaq\/","name":"BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: HilleVax, Inc. (Nasdaq \u2013 HLVX), Steelcase Inc. (NYSE \u2013 SCS), LAVA Therapeutics N.V. (Nasdaq\u00a0\u2013 LVTX), Arcadia Biosciences, Inc. (Nasdaq\u00a0\u2013 RKDA) - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-hillevax-inc-nasdaq-hlvx-steelcase-inc-nyse-scs-lava-therapeutics-n-v-nasdaq\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-hillevax-inc-nasdaq-hlvx-steelcase-inc-nyse-scs-lava-therapeutics-n-v-nasdaq\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUwNTU3NiM3MDgwMTMzIzIxODgyNzg=","datePublished":"2025-08-04T18:19:40+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-hillevax-inc-nasdaq-hlvx-steelcase-inc-nyse-scs-lava-therapeutics-n-v-nasdaq\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-hillevax-inc-nasdaq-hlvx-steelcase-inc-nyse-scs-lava-therapeutics-n-v-nasdaq\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-hillevax-inc-nasdaq-hlvx-steelcase-inc-nyse-scs-lava-therapeutics-n-v-nasdaq\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUwNTU3NiM3MDgwMTMzIzIxODgyNzg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUwNTU3NiM3MDgwMTMzIzIxODgyNzg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-hillevax-inc-nasdaq-hlvx-steelcase-inc-nyse-scs-lava-therapeutics-n-v-nasdaq\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: HilleVax, Inc. (Nasdaq \u2013 HLVX), Steelcase Inc. (NYSE \u2013 SCS), LAVA Therapeutics N.V. (Nasdaq\u00a0\u2013 LVTX), Arcadia Biosciences, Inc. (Nasdaq\u00a0\u2013 RKDA)"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/870246","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=870246"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/870246\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=870246"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=870246"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=870246"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}